Onesource shares fall up to 7% on semaglutide supply delay, guidance cut from key client
Shares of Onesource Specialty Pharma Ltd. declined up to 7% on Friday, July 10, after reacting to Dr Reddy’s Laboratories’ semaglutide batch concerns and supply delay. The stock though, has recovered from its opening lows. Onesource Specialty Pharma undertakes the final stage of production before the semglutide drug is shipped to pharmaceutical companies. It operates…
